Probitic in chronic urticaria

Phase 3

• Conditions: Chronic urticaria.; Idiopathic urticaria; L50.1

• Registration Number: IRCT20110531006660N9
• Lead Sponsor: Mazandaran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 August 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Resistant chronic urticaria
5 to 30 years old

Exclusion Criteria

Consumption of probiotic in the last 2 months
Second urticaria
other Known disorders
consumption of antibiotic in the last 2 months

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Resolution chronic urticaria severity. Timepoint: Before, 4 and 8 weeks after treatment. Method of measurement: Questionnaire- UAS7 and QOLI.

Secondary Outcome Measures

Name	Time	Method
Resolution chronic urticaria quality of life. Timepoint: Before, 4 and 8 weeks after treatment. Method of measurement: Questionnaire.